Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (41-50 of 403) with videos related to

Pageof 41
Sort By:
British Journal of Haematology|November 5, 2013
CXCR4 blockade and sphingosine-1-phosphate activation facilitate engraftment of haematopoietic stem and progenitor cells in a non-myeloablative transplant modelNona Shayegi, Claudia Meyer, Katrin Lambert, et al.
Haematologica|June 3, 2011
Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?Franziska Taube, Friedrich Stölzel, Christian Thiede, et al.
Annals of Hematology|May 23, 2009
Imatinib in breast milkRoland Kronenberger, Eberhard Schleyer, Martin Bornhäuser, et al.
Leukemia Research|May 4, 2004
Cross-trial networking in AML: a step forward rather than corner cuttingThomas Büchner, Hartmut Döhner, Gerhard Ehninger, et al.
British Journal of Haematology|May 15, 2004
A sensitive model for prediction of relapse in adult acute myeloid leukaemia with t(8;21) using white blood cell count, CD56 and MDR1 gene expression at diagnosisMarkus Schaich, Rainer Koch, Silke Soucek, et al.
Haematologica|June 4, 2008
Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantationUwe Platzbecker, Marc Binder, Christoph Schmid, et al.
Haematologica|July 15, 2003
Normal intrinsic Th1/Th2 balance in patients with chronic phase chronic myeloid leukemia not treated with interferon-alpha or imatinibAlexander Kiani, Ivonne Habermann, Knut Schäke, et al.
Experimental Hematology|February 14, 2009
Direct contact with mesenchymal stromal cells affects migratory behavior and gene expression profile of CD133+ hematopoietic stem cells during ex vivo expansionNael Alakel, Duohui Jing, Katrin Muller, et al.
Leukemia & Lymphoma|August 10, 2011
A NME1 promoter SNP predicts Ara-C associated neurotoxicity in AML patientsDominic Braunagel, Markus Schaich, Michael Kramer, et al.
Haematologica|November 12, 2009
Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximabMartin Wermke, Malte von Bonin, Siegmund Gehrisch, et al.
Pageof 41

Showing results (41-50 of 403) with videos related to

Sort By:
Pageof 41
British Journal of Haematology|November 5, 2013
CXCR4 blockade and sphingosine-1-phosphate activation facilitate engraftment of haematopoietic stem and progenitor cells in a non-myeloablative transplant modelNona Shayegi, Claudia Meyer, Katrin Lambert, et al.
Haematologica|June 3, 2011
Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?Franziska Taube, Friedrich Stölzel, Christian Thiede, et al.
Annals of Hematology|May 23, 2009
Imatinib in breast milkRoland Kronenberger, Eberhard Schleyer, Martin Bornhäuser, et al.
Leukemia Research|May 4, 2004
Cross-trial networking in AML: a step forward rather than corner cuttingThomas Büchner, Hartmut Döhner, Gerhard Ehninger, et al.
British Journal of Haematology|May 15, 2004
A sensitive model for prediction of relapse in adult acute myeloid leukaemia with t(8;21) using white blood cell count, CD56 and MDR1 gene expression at diagnosisMarkus Schaich, Rainer Koch, Silke Soucek, et al.
Haematologica|June 4, 2008
Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantationUwe Platzbecker, Marc Binder, Christoph Schmid, et al.
Haematologica|July 15, 2003
Normal intrinsic Th1/Th2 balance in patients with chronic phase chronic myeloid leukemia not treated with interferon-alpha or imatinibAlexander Kiani, Ivonne Habermann, Knut Schäke, et al.
Experimental Hematology|February 14, 2009
Direct contact with mesenchymal stromal cells affects migratory behavior and gene expression profile of CD133+ hematopoietic stem cells during ex vivo expansionNael Alakel, Duohui Jing, Katrin Muller, et al.
Leukemia & Lymphoma|August 10, 2011
A NME1 promoter SNP predicts Ara-C associated neurotoxicity in AML patientsDominic Braunagel, Markus Schaich, Michael Kramer, et al.
Haematologica|November 12, 2009
Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximabMartin Wermke, Malte von Bonin, Siegmund Gehrisch, et al.
Pageof 41